EverQuote's Growth Is No Fluke

Feb. 25, 2020 11:48 AM ETEverQuote, Inc. (EVER) StockEVER5 Comments
Gary Alexander
31.39K Followers

Summary

  • In Q3, EverQuote shocked investors when it suddenly accelerated its revenue growth to 61% y/y.
  • In releasing its Q4 results, EverQuote shocked and delighted investors again when it showed further acceleration to an 85% y/y growth rate.
  • Viewed from this lens, the company's FY20 guidance calling for 27-31% y/y growth is heavily conservative and leaves plenty of room for upside.
  • EverQuote has also made use of its tremendous growth to drive notable improvements in adjusted EBITDA.

Over the past year, EverQuote (NASDAQ:EVER) has transformed from a sleepy small-cap IPO that no one has ever heard of to an explosive stock that has seen its share price grow by nearly 10x over the past year. The question for investors following EverQuote now is: is EverQuote simply a gimmicky, speculative stock, or is there real fundamental strength behind its phenomenal stock rise?

EverQuote just reported fourth-quarter results, which represents the strongest growth it's seen on record. Yet investors sent shares down modestly after the earnings release, signaling that investors are skeptical about the future - especially EverQuote's conservative fiscal 2020 guidance.

Let's cut to the chase: in my view, there's plenty of upside left for EverQuote. In my view, the bullish case for this stock lies on the following drivers:

  • Huge potential for disruption in the insurance space. EverQuote is one of the only publicly traded stocks in the so-called "InsurTech" space, which is among the last bastions of industries that have yet to be radically transformed by technology and software. Right now, EverQuote's technology helps consumers sift through the mind-boggling number of options in getting insurance quotes.
  • Growth in new categories. EverQuote's bread-and-butter is automotive insurance, but its recent expansion into home and life has been extremely lucrative, seeing revenue growth of 130% y/y in Q4. The number of categories EverQuote could enter is endless, and provides plenty of head room for growth.
  • Benefiting from economies of scale. As a web business, EverQuote benefits from high >90% gross margins. As its scale has grown, it has succeeded in transforming losses into profitability, at least on an adjusted EBITDA basis. Recent trends suggest EverQuote may hit GAAP profitability as soon as next year, which is a major distinguisher for a recent IPO.
  • Undemanding valuation. Yes, EverQuote's

This article was written by

31.39K Followers
With combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. He has been a regular contributor on Seeking Alpha since 2017. He has been quoted in many web publications and his articles are syndicated to company pages in popular trading apps like Robinhood.

Analyst’s Disclosure:I am/we are long EVER. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

About EVER Stock

SymbolLast Price% Chg
Market Cap
PE
Yield
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on EVER

Related Stocks

SymbolLast Price% Chg
EVER
--